Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers von Fossard, G., Broussais, F., Coelho, I., Bailly, S., Nicolas-Virelizier, E., Toussaint, E., Lancesseur, C., Le Bras, F., Willems, E., Tchernonog, E., Chalopin, T., Delarue, R., Gressin, R., Chauchet, A., Gyan, E., Cartron, G., Bonnet, C., Haioun, C., Damaj, G., Gaulard, P., Fornecker, L., Ghesquières, H., Tournilhac, O., da Silva, M. Gomes, Bouabdallah, R., Salles, G., Bachy, E.

Volltext

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial von Rossille, D, Gressier, M, Damotte, D, Maucort-Boulch, D, Pangault, C, Semana, G, Le Gouill, S, Haioun, C, Tarte, K, Lamy, T, Milpied, N, Fest, T

Volltext

Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases von BAREAU, Benoit, REY, Jérôme, LAMY, Thierry, HAMIDOU, Mohamed, DONADIEU, Jean, MORCET, Jeff, REMAN, Oumedaly, SCHLEINITZ, Nicolas, TOURNILHAC, Olivier, ROUSSEL, Mikael, FEST, Thierry

Volltext

Front-line chemo-immunotherapy is not inferior to ibrutinib in CLL von van Gelder, M., Tournilhac, O., te Raa, D., Visser, H.P.J.

Volltext

Cyclophosphamide as a first-line therapy in LGL leukemia von Moignet, A, Hasanali, Z, Zambello, R, Pavan, L, Bareau, B, Tournilhac, O, Roussel, M, Fest, T, Awwad, A, Baab, K, Semenzato, G, Houot, R, Loughran, T P, Lamy, T

Volltext

Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC von Tessoulin, B, Ceballos, P, Chevallier, P, Blaise, D, Tournilhac, O, Gauthier, J, Maillard, N, Tabrizi, R, Choquet, S, Carras, S, Ifrah, N, Guillerm, G, Mohty, M, Tilly, H, Socie, G, Cornillon, J, Hermine, O, Daguindau, É, Bachy, E, Girault, S, Marchand, T, Oberic, L, Reman, O, Leux, C, Le Gouill, S

Volltext

Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial von TAVERNIER, E, BOIRON, J.-M, TOURNILHAC, O, BUZYN, A, REMAN, O, CHARRIN, C, BOUCHEIX, C, GABERT, J, LHERITIER, V, VERNANT, J.-P, DOMBRET, H, THOMAS, X, HUJUET, F, BRADSTOCK, K, VEY, N, KOVACSOVICS, T, DELANNOY, A, FEGUEUX, N, FENAUX, P, STAMATOULLAS, A

Volltext

Corrigendum to ‘Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA cent... von Fossard, G., Broussais, F., Coelho, I., Bailly, S., Nicolas-Virelizier, E., Toussaint, E., Lancesseur, C., Le Bras, F., Willems, E., Tchernonog, E., Chalopin, T., Delarue, R., Gressin, R., Chauchet, A., Gyan, E., Cartron, G., Bonnet, C., Haioun, C., Damaj, G., Gaulard, P., Fornecker, L., Ghesquières, H., Tournilhac, O., Gomesda Silva, M., Bouabdallah, R., Salles, G., Bachy, E.

Volltext

Five‐year subgroup analysis of tafasitamab + lenalidomide from the Phase II L‐MIND study in patients with relapsed or refractory diffuse large B‐cell lymphoma von Duell, J., Abrisqueta, P., Dreyling, M., Gaidano, G., Barca, E. G., Jurczak, W., Maddocks, K. J., Menne, T., Nagy, Z., Tournilhac, O., Bakuli, A., Amin, A., Gurbanov, K., Salles, G.

Volltext

KILT: A RANDOMIZED NON‐COMPARATIVE PHASE II LYSA STUDY OF LACUTAMAB WITH GEMOX VERSUS GEMOX IN RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA von Cheminant, M., Carras, S., Bruneau, J., Lemonnier, F., Bachy, E., Herbaux, C., Feugier, P., Daguindau, N., Gastinne, T., Guillermin, Y., Lamarque, M., Slama, B., Wolfromm, A., Morschhauser, F., Tournilhac, O., Gaulard, P., Asnafi, V., Ortonne, N., Damaj, G., Hermine, O.

Volltext

Cell‐free DNA sequencing allows the identification of the mutational profile of TFH lymphomas and has a predictive value: a LYSA study von Sako, N., Delfau, M., Bachy, E., Morschhauser, F., Cartron, G., Casasnovas, O., Gressin, R., Daguindau, N., Tournilhac, O., Bouabdallah, K., Le Gouill, S., Andre, M., Robe, C., Dupuis, J., Leval, L., Gaulard, P., Lemonnier, F.

Volltext

Five‐year efficacy and safety of tafasitamab in patients with relapsed or refractory DLBCL: Final results from the Phase II L‐MIND study von Duell, J., Abrisqueta, P., Andre, M., Augustin, M., Gaidano, G., Barca, E. G., Jurczak, W., Kalakonda, N., Liberati, A. M., Maddocks, K. J., Menne, T., Nagy, Z., Tournilhac, O., Bakuli, A., Amin, A., Gurbanov, K., Salles, G.

Volltext

Characterization of familial Waldenstrom's macroglobulinemia von TREON, S. P, HUNTER, Z. R, TOURNILHAC, O, PATTERSON, C. J, MANNING, R, BRANAGAN, A. R, MORTON, C. C, AGGARWAL, A, EWEN, E. P, MASOTA, S, LEE, C, DITZEL SANTOS, D, HATJIHARISSI, E, XU, L, LELEU, X

Volltext

Aggressive skin cancers in patients who experienced chronic GvHD after allogeneic bone marrow transplantation von Zampaolo, A S, Kanold, J, Tournilhac, O, Franck, F, Bachelerie, M, D'Incan, M

Volltext

Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience von Le Gouill, S., Kröger, N., Dhedin, N., Nagler, A., Bouabdallah, K., Yakoub-Agha, I., Kanouni, T., Bulabois, C.E., Tournilhac, O., Buzyn, A., Rio, B., Moles, M.P., Shimoni, A., Bacher, U., Ocheni, S., Milpied, N., Harousseau, J.L., Moreau, P., Leux, C., Mohty, M.

Volltext

Efficacy of anti‐PD1 therapy in relapsed or refractory NK/T cell lymphoma: a matched cohort analysis from the LYSA von Marouf, A., Chaubard, S., Michot, J., Liévin, R., Rossignol, J., Golfier, C., Allangba, O., Philippe, L., Tessoulin, B., Chauchet, A., Deau, B., Oberic, L., Vargaftig, J., Moignet, A., Clavert, A., Dulery, R., Brisou, G., Tardy, S., Fataccioli, V., Houot, R., Casasnovas, R., Thieblemont, C., Ghesquières, H., Carras, S., Le Gouill, S., Cartron, G., Marabelle, A., Tournilhac, O., Damaj, G., Gaulard, P., Leval, L., Lemonnier, F., Bachy, E., Hermine, O., Couronné, L., Jaccard, A.

Volltext

MOLECULAR CHARACTERIZATION CONTRIBUTES TO DIAGNOSIS AND PREDICTS OUTCOME IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMAS: A LYSA STUDY von Camus, V., Viailly, P., Sesques, P., Drieux, F., Veresezan, E., Haioun, C., Durot, E., Patey, M., Rossi, C., Martin, L., Rainville, V., Bohers, E., Ruminy, P., Viennot, M., Paillassa, J., Tournilhac, O., Willaume, A., Antier, C., Lazarovici, J., Lévêque, E., Decazes, P., Becker, S., Tonnelet, D., Berriolo‐Riedinger, A., Gaulard, P., Tilly, H., Molina, T. J., Traverse‐Glehen, A., Jardin, F.

Volltext

Allogeneic transplantation in T‐cell lymphoma: Lessons from the AATT study von Tournilhac, O., Altmann, B., Friedrichs, B., Bouabdallah, K., Cartron, G., Nickelsen, M., Wulf, G., Leclerc, M., Vilatte, A., Turlure, P., Sanhès, L., Houot, R., Roussel, M., Leval, L., Rosenwald, A., Gaulard, P., Dreger, P., Glass, B., Latière, C., Damaj, G., Lenz, G., Reimer, P., Banos, A., Bilger, K., Durot, E., Sibon, D., Wagner, E., Nguyen, S., Trümper, L., Ziepert, M., Schmitz, N.

Volltext

FDG-PET/CT findings in systemic mastocytosis: a French multicentre study von Djelbani-Ahmed, S., Chandesris, M. O., Mekinian, A., Canioni, D., Brouzes, C., Hanssens, K., Pop, G., Durieu, I., Durupt, S., Grosbois, B., Besnard, S., Tournilhac, O., Beyne-Rauzy, O., Agapé, P., Delmer, A., Ranta, D., Jeandel, P. Y., Georgin-Lavialle, S., Frenzel, L., Damaj, G., Eder, V., Lortholary, O., Hermine, O., Fain, O., Soussan, M.

Volltext

Impact of uncontrolled freezing and long-term storage of peripheral blood stem cells at −80 °C on haematopoietic recovery after autologous transplantation. Report from two centres... von Detry, G, Calvet, L, Straetmans, N, Cabrespine, A, Ravoet, C, Bay, J O, Petre, H, Paillard, C, Husson, B, Merlin, E, Boon-Falleur, L, Tournilhac, O, Delannoy, A, Halle, P

Volltext